Bharat Biotech seeks full marketing approval from DCGI for Covaxin
The company, however, is yet to submit the full follow up data of clinical trial of Covaxin to DCGI, a source said.
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.